We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > MPP

News List

Research Progress on the Pathogenesis and Clinical Diagnosis of Mycoplasma Pneumoniae Pneumonia Xiaomichong
June 26, 2024
Mycoplasmal Pneumonia Pneumonia (MPP), also known as primary atypical pneumonia or cold agglutinin-positive pneumonia, is a common respiratory disease among children caused by infection with Mycoplasmal pneumoniae (MP), which frequently occurs in school-a
Pfizer and MPP to expand COVID-19 oral antiviral treatment access EuropeanPharmaceuticalReview
November 18, 2021
Pfizer and the Medicines Patent Pool (MPP), a United Nations (UN)-backed public health organisation, have announced the signing of a voluntary license agreement for Pfizer’s COVID-19 oral antiviral treatment...
India, China to produce generic of Gilead's TAF biospectrumasia
October 12, 2018
India, China to produce generic of Gilead's TAF
MPP signs licence and technology transfer agreement with Pharco Pharmaceuticals for RAV pharmaceutical-technology
April 25, 2017
Public health organisation Medicines Patent Pool (MPP) has entered a new licence and technology transfer agreement...